TickerFactsScreenerDevelopers

Outlook Therapeutics, Inc. (OTLK) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2014: $2.35M2015: $9.07M2016: $2.35M2017: $3.19M2018: $1.72M2019: $8.02M2020: $12.54M2021: $14.48M2022: $17.40M2023: $23.39M2024: $14.93M2025: $8.08M$8.08M
2014Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$8.08M-45.9%
2024$14.93M-36.2%
2023$23.39M+34.5%
2022$17.40M+20.2%
2021$14.48M+15.5%
2020$12.54M+56.4%
2019$8.02M+366.7%
2018$1.72M-46.1%
2017$3.19M+35.4%
2016$2.35M-74.1%
2015$9.07M+286.1%
2014$2.35M—